急性心肌梗死的当代处理仍然以积极药物治疗为基础

急性心肌梗死（AMI）的治疗主要涉及药物和介入两个方面。及时有效的介入治疗能迅速开通阻塞的冠状动脉、拯救濒危心肌，降低AMI病人的病死率和病残率。介入治疗、特别是急诊情况下直接介入治疗受限条件较多。如能实施强化的药物治疗，临床效益并不次于介入治疗。因此，AMI的当代处理仍然应该以最佳的药物治疗作为基础。

Current Management of Acute Myocardial Infarction Should Still be Based upon High-quality Medical Care

Management of acute myocardial infarction (AMI) involves pharmacological treatment and percutaneous coronary interventions (PCI). An effective PCI can promptly restore blood flow in the infarcted artery and improve myocardial perfusion and clinical outcomes. However, there are no capacities for PCI or for primary PCI in some hospitals. In addition, there are many studies to suggest that the clinical benefits by intensive medical management, including aspirin, ACE inhibitors and beta-blockers, as well as thrombolysis,are not inferior to that by more intensive invasive strategy. Thus, current management of AMI should still be based upon high-quality medical care, which could be accomplished in most hospitals without additional facilities.